VICTORY CAPITAL MANAGEMENT INC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,039
-51.7%
16,738
+4.7%
0.00%
Q2 2023$20,788
-19.8%
15,991
+8.6%
0.00%
Q1 2023$25,916
-44.7%
14,725
-1.3%
0.00%
Q4 2022$46,865
-35.8%
14,925
-0.0%
0.00%
Q3 2022$73,000
+10.6%
14,931
-5.9%
0.00%
Q2 2022$66,0000.0%15,868
-0.2%
0.00%
Q1 2022$66,000
-45.9%
15,897
-2.6%
0.00%
Q4 2021$122,000
-20.3%
16,318
-4.0%
0.00%
Q3 2021$153,000
-26.8%
17,005
-2.6%
0.00%
Q2 2021$209,000
-7.1%
17,457
-2.6%
0.00%
Q1 2021$225,000
-21.1%
17,921
-1.8%
0.00%
Q4 2020$285,000
+77.0%
18,245
+7.1%
0.00%
Q3 2020$161,000
-1.2%
17,034
-6.6%
0.00%
Q2 2020$163,000
-31.5%
18,239
-51.2%
0.00%
Q1 2020$238,000
+25.9%
37,382
+65.4%
0.00%
Q4 2019$189,000
+6.8%
22,604
+15.8%
0.00%
Q3 2019$177,00019,5260.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders